IP Library Granted Patent US 7,081,479
Granted Patent B2
US 7,081,479 · App. 10/768,359 · Granted Jul 25, 2006

Treatment of acne using alkonolamine compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,081,479
App. No.
10/768,359
Granted
Jul 25, 2006
Kind
B2
Abstract

Acne is treated or prevented by the topical application of compositions containing an alkanolamine such as dimethylaminoethanol, tyrosine, and a sulfur ingredient such as lipoic acid or glutathione. Adjunct ingredients such as fatty acid esters of ascorbic acid, e.g., ascorbyl palmitate and α-hydroxy acids may be included in the formulations. Compositions of the invention may be used alone, or, in many preferable embodiments, in combination with conventional acne medications such as anti-acne products containing salicylic acid, benzoyl peroxide, or a retinoid. In these embodiments, alkanolamine compositions of the invention are applied to affected skin areas first, and then a conventional acne medication is applied. This maximizes the efficacy of the treatment while minimizing skin irritation caused by conventional medications.

Claims (10)

1. A topical acne composition consisting of

a) from about 0.1% to about 10% by weight of an alkanolamine of the formula

wherein X, Y and Z are selected from the group consisting of hydrogen, C1–C3 alkyl groups, C2–C4 alkanol group, wherein at least one of X, Y, or Z is a C2–C4 alkanol group bearing at least one hydroxyl group and optionally at least one carboxyl group;

b) from about 0.01% to about 6% by weight tyrosine;

c) from about 0.01% to about 10% by weight of a sulfur-containing ingredient selected from the group consisting of lipoic acid, glutathione, and mixtures thereof;

d) a dermatologically acceptable carrier; and optionally, an adjunct ingredient selected from the group consisting an α-hydroxy acid, a fatty acid ester of ascorbic acid, and mixtures of any of these, wherein the topical composition is applied to skin and acts upon the skin to treat acne.

2. A composition according to claim 1 which consists of from about 0.03% to about 5% by weight dimethylaminoethanol, from about 0.03% to about 5% by weight tyrosine, and from about 0.1% to about 10% by weight lipoic acid, glutathione, and mixtures thereof.

3. A composition according to claim 2 which consists of from about 1% to about 3% by weight dimethylaminoethanol, from about 0.2% to about 0.5% by weight tyrosine, and from about 2% to about 7% by weight lipoic acid.

4. A composition according to claim 2 which consists of from about 1% to about 3% by weight dimethylaminoethanol, from about 0.2% to about 0.5% by weight tyrosine, and from about 5% to about 10% by weight glutathione.

5. A composition according to claim 1 wherein α-hydroxy acid is from about 1% to about 10% a by weight glycolic acid.

Assignments (4)
SECURITY INTEREST Recorded Jun 5, 2015
From: N.V. PERRICONE LLC
To: THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY, AS ADMINISTRATIVE AGENT
Reel/Frame 035833/0948 →
RELEASE OF SECURITY INTEREST Recorded Jun 5, 2015
From: MUFG UNION BANK, N.A., AS AGENT FORMERLY KNOWN AS UNION BANK OF CALIFORNIA, N.A., AS AGENT
To: N.V. PERRICONE LLC
Reel/Frame 035835/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2007
From: PERRICONE, NICHOLAS V.
To: N. V. PERRICONE LLC
Reel/Frame 018837/0240 →
SECURITY AGREEMENT Recorded Mar 6, 2006
From: N.V. PERRICONE LLC
To: UNION BANK OF CALIFORNIA, N.A., AS AGENT FOR THE LENDERS
Reel/Frame 017251/0780 →
Continuity (3)
Division 1008586400 · Feb 27, 2002
Continuation In Part 0990068000 · Jul 6, 2001
Related Publication 20040185076A1 · Sep 23, 2004